Global Health Ltd
MEDANTAGlobal Health Ltd
MEDANTA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 61.28 | 10.50 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 50.26 | 6.38 | 0.53% |
Forecast & Ratings
Detailed Forecast from 10 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Global Health Limited, formerly Global Health Private Limited, is an India-based company. The Company is a tertiary care provider operating in the North and East regions of India. The Company operates approximately four hospitals under Medanta brand
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Narayana Hrudayalaya Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,439.86 | 1,344.00 | 1,392.14 | 1,505.82 | 1,515.63 | 1,255.75 | 1,800.00 | 2,021.13 | 2,382.88 | 3,548.35 | ||||||||||
Raw Materials | 323.98 | 287.89 | 313.43 | 324.92 | 319.21 | 301.73 | 451.23 | 459.11 | 540.96 | 2,652.82 | ||||||||||
| Power & Fuel Cost | 29.22 | 30.63 | 29.55 | 30.65 | 31.11 | 27.43 | 31.80 | 36.84 | 35.86 | |||||||||||
| Employee Cost | 472.67 | 518.07 | 526.60 | 540.72 | 522.30 | 415.91 | 494.66 | 532.91 | 591.06 | |||||||||||
| Selling & Administrative Expenses | 140.90 | 170.86 | 211.56 | 244.28 | 116.95 | 271.25 | 327.42 | 411.71 | 488.02 | |||||||||||
| Operating & Other expenses | 118.55 | 151.10 | 137.01 | 156.91 | 264.02 | 38.16 | 79.06 | 110.94 | 120.75 | |||||||||||
EBITDA | 354.54 | 185.45 | 173.99 | 208.34 | 262.04 | 201.27 | 415.83 | 469.62 | 606.23 | 895.53 | ||||||||||
| Depreciation/Amortization | 71.57 | 77.35 | 86.36 | 90.69 | 98.57 | 87.64 | 87.17 | 86.09 | 87.09 | 185.48 | ||||||||||
| PBIT | 282.97 | 108.10 | 87.63 | 117.65 | 163.47 | 113.63 | 328.66 | 383.53 | 519.14 | 710.05 | ||||||||||
| Interest & Other Items | 16.53 | 19.05 | 23.56 | 21.13 | 32.54 | 29.20 | 32.83 | 31.82 | 30.46 | 69.87 | ||||||||||
| PBT | 266.44 | 89.05 | 64.07 | 96.52 | 130.93 | 84.43 | 295.83 | 351.71 | 488.68 | 640.18 | ||||||||||
| Taxes & Other Items | 91.51 | 34.70 | 26.74 | 33.58 | 28.18 | 27.14 | 77.04 | 88.46 | 127.78 | 152.06 | ||||||||||
| Net Income | 174.93 | 54.35 | 37.33 | 62.94 | 102.75 | 57.29 | 218.79 | 263.25 | 360.90 | 488.12 | ||||||||||
| EPS | 7.21 | 2.24 | 1.53 | 2.57 | 4.17 | 2.32 | 8.73 | 10.10 | 13.45 | 18.18 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Global Health Ltd | 82.88 | 10.50 | — |
| Apollo Hospitals Enterprise Ltd | 110.97 | 13.62 | 0.23% |
| Max Healthcare Institute Ltd | 91.91 | 11.56 | 0.15% |
| Fortis Healthcare Ltd | 86.46 | 6.05 | 0.15% |
Price Comparison
Compare MEDANTA with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Global Health Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Kotak Emerging Equity Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.4364% | Percentage of the fund’s portfolio invested in the stock 1.44% | Change in the portfolio weight of the stock over the last 3 months 0.29% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/75 (-3) |
UTI Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7762% | Percentage of the fund’s portfolio invested in the stock 0.84% | Change in the portfolio weight of the stock over the last 3 months 0.41% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/70 (+13) |
Canara Robeco Emerging Equities - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7635% | Percentage of the fund’s portfolio invested in the stock 0.95% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 62/96 (0) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MEDANTA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet profit of Global Health rose 4.54% to Rs 130.84 crore in the quarter ended September 2024 as against Rs 125.16 crore during the previous quarter ended September 2023. Sales rose 13.34% to Rs 956.56 crore in the quarter ended September 2024 as against Rs 843.94 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales956.56843.94 13 OPM %23.8625.22 - PBDT230.53213.51 8 PBT181.10170.60 6 NP130.84125.16 5 Powered by Capital Market - Live
Global Health will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Global Health announced that the Company has signed an Operations and Management Agreement with Dr. Narayan Dutt Shirmali Foundation International Charitable Trust Society (Society) to operate and manage a ~750 bed super specialty hospital in Pitampura, New Delhi. The hospital is expected to commence operations in ~4 years, subject to necessary statutory and customary approvals. As per the agreement, the hospital building and associated civil infrastructure will be developed by the Society and Medanta will make the necessary investments in internal fitouts, MEP, furniture and medical equipment. Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years, to be funded by a combination of internal accruals and debt financing. Medanta will have full control over the day to day running of the hospital. The agreement is for an initial term of 30 years, further extendable on mutually agreeable terms. The hospital will be located on a 7-acre site in Pitampura, New Delhi, with a total builtup area of 7.6 Lakh sq.ft excluding the basement. The site offers good connectivity to the Outer Ring road and is in close proximity to high-density residential areas, which will enable Medanta to serve the region's growing healthcare needs. The state-of-the-art ~750 bedded super-specialty hospital will cater to over 30 super specialties including cardiac, neurosciences, cancer, orthopaedics, digestive, hepatobiliary sciences, multispecialty robotic surgeries, regenerative medicine, as well as full range of transplants. Powered by Capital Market - Live
Global Health announced that the 20th Annual General Meeting (AGM) of the company will be held on 19 September 2024.Powered by Capital Market - Live
Net profit of Global Health rose 4.20% to Rs 106.29 crore in the quarter ended June 2024 as against Rs 102.01 crore during the previous quarter ended June 2023. Sales rose 10.45% to Rs 861.08 crore in the quarter ended June 2024 as against Rs 779.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales861.08779.58 10 OPM %21.6423.66 - PBDT190.27181.43 5 PBT143.65141.04 2 NP106.29102.01 4 Powered by Capital Market - Live
Global Health will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live
Global Health has been offered by Mumbai Housing and Area Development Authority (MHADA) vide its letter dated 22 July 2024 a land parcel measuring 8859.24 sq. meters for an amount of Rs 125.11 crores (approx.) on lease basis under online e-tenders issued by MHADA. The aforesaid land parcel is situated at Mauje-Oshiwara, Jogeshwari, CTS No. 31, 32 (part), 33 (part), 37 (part), Mumbai, Maharashtra and can accommodate construction of a 500+ bedded hospital with an estimated project capex of Rs. 1,200 crore, subject to various customary and statutory approvals. The detailed business plan for the construction of above mentioned 500+ bedded hospital is subject to approval of Board of the Company and the Company will update the stock exchanges on any material developments relating to this matter. Powered by Capital Market - Live
Reliance Infrastructure Ltd leads losers in ‘A’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.61%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 4.11% to 3.86%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 41.81%, vs industry avg of 42.9%